Blood markers study for people with lupus
Part of Immune system & allergy, Skin clinical trials.
This study looks at two substances in the blood (miR-101-3p and autotaxin) in people with lupus compared to healthy people, to see if they can help doctors understand the disease better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older.
- You must have been diagnosed with systemic lupus erythematosus (SLE), also called lupus.
- You must be willing to participate and sign a consent form.
- You cannot be pregnant or breastfeeding.
- You cannot have an active infection or cancer.
- You cannot have other autoimmune diseases besides lupus.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood test results in people with lupus compared to healthy people. It may help doctors understand lupus better and improve care.
This study looks at how certain immune cells (natural killer T cells) behave in people with systemic lupus, by measuring specific immune receptor markers in blood. It may help researchers better understand lupus and how it can connect with other conditions like antiphospholipid syndrome or Sjögren’s.
This study looks at blood and immune cell markers (autoantibodies and immune cell “signatures”) to better understand autoimmune conditions, including lupus. It may help researchers identify which markers are linked to disease and how immune cells respond after vaccination.
This study aims to see if a blood test that measures a specific protein-related molecule can help doctors know how active your lupus is. If successful, this could lead to a simpler way to monitor the disease and adjust treatment.
This study looks at whether two blood test markers (called T IgG and T IgM) can help doctors understand how active your lupus is and how much damage the disease has caused. If you join, your blood will be tested, and the results may help guide your treatment.
This study looks at whether simple blood tests can help doctors better understand and track kidney problems that occur in people with lupus. The goal is to see if these markers can predict how the disease will progress, which could help guide treatment.
Hear when a new Systemic Lupus Erythematosus (SLE) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.